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 Abstract: 
Study materials and methods. In recent years, it is relevant to study the relationship of frailty with the outcome of treatment of 
patients with ischemic heart disease (IHD) and developed acute coronary syndrome (ACS). The goal of this study was to study 
the course and outcome of acute coronary syndrome with ST-segment elevation and without ST-segment elevation in patients of 
older age groups with frailty. The research was a retrospective, current and prospective study of the registers of patients with 
acute coronary syndrome within the framework of the international project “GIRAFFE – Gerontological Research International 
Against Frailty: Fit Experience”. 1635 patients with IHD were examined (1002 patients of middle age, 633 patients of elderly 
and senile age). Frailty was diagnosed in 368 patients of elderly and senile age, 265 patients had no frailty. One of four 
treatment strategies was chosen for patients under study: emergency invasive, early invasive, late (delayed) invasive and 
conservative. Study results. The evaluation of unfavorable coronary events carried out according to the criteria of MACE (Major 
Adverse Coronary Events) showed that in patients with ACS with ST-segment elevation, as well as in patients without ST-segment 
elevation receiving conservative therapy, the risk of adverse cardiac events is higher than in patients undergoing invasive 
therapy. When joining frailty syndrome, the development of adverse cardiac events increases significantly. The excess of the 
average intrahospital lethality was observed only in elderly and senile patients with frailty, what proved the necessity of 
correction of frailty in order to improve the results of treatment of patients with ACS with ST-segment elevation and without ST-
segment elevation by leveling the negative impact of frailty on the outcome of treatment of acute coronary syndrome 
Keywords: acute coronary syndrome, frailty, elderly and senile age 
* Corresponding author:  
Svetlana G. Gorelik,  
 "Belgorod State University", Belgorod, 
 Russia (85, Pobedy Str., Belgorod, Russia, 308015),  
e-mail: gorelik@bsu.edu.ru 
 
 
Please cite this article in press Svetlana G. Gorelik et al., Course of acute coronary syndrome in patients with 
frailty., Indo Am. J. P. Sci, 2018; 05(07). 
 
 
QR code 
 
 
IAJPS 2018, 05 (07), 6992-6997                Svetlana G. Gorelik et al                 ISSN 2349-7750 
 
 
 
w w w . i a j p s . c o m  
 
Page 6993 
INTRODUCTION: 
Coronary heart disease (CHD) is one of the most 
common diseases in the world. Acute coronary 
syndrome (ACS) – is a form of CHD, threatening life 
and requiring active treatment.  There are many 
prognostic scales for prediction of acute coronary 
syndrome failures, however, there are no prognostic 
scales for stratification of cardiovascular risk and 
patients’ status evaluation.  [1-4]. Mostly it is 
necessary for older and senile patients with high risk 
of polymorbidity and frailty development, which is 
accompanied by expressed life activity suppression 
and body rehabilitation ability limitation, which is 
extremely important for patients, who had acute 
coronary syndrome [5-9]. 
 
One of the leading methods for treatment of acute 
coronary syndrome along with antiplatelet, 
anticoagulant and anti-ischemic therapy, is in time 
myocardium reperfusion. Myocardium reperfusion 
allows to reduce the necrotic zone significantly, 
hence decreasing mortality and improving prognosis 
for patients with ACS [5,7,9,10]. It is stated in the 
latest European Guidelines, that for treatment of 
patients having ACS with ST elevation in the first 12 
hours from the beginning of the disease the chosen 
reperfusion therapy method is primary angioplasty 
and stenting [67]. It is considered to be a good 
indicator if door-to-balloon time does not exceed 120 
minutes [10-11].  
 
Treatment strategies for patients with ACS without 
ST elevation depends on the severity of the patients’ 
condition and risks of complications and is subject to 
European recommendations for treatment of ACS 
without ST elevation issued in 2015 [3,11]. Various 
scales are used to evaluate risks of complications. 
Choice of approach is specified by the European 
Guidelines for the managements of ACS without ST 
elevation [3,4,9]. Thus, patients with cardiogenic 
shock or those who underwent resuscitation 
procedures are subject to immediate coronagraphy 
according to the mentioned guidelines.  
 
It should be noted that all recommendations and 
scales for diagnostics and treatment of patients with 
CHD with ACS development are designed on the 
basis of the patient’s condition severity depending on 
the progress of CHD with development of ACS. 
There are no scales and guidelines considering 
severity of physical functions loss, which leads to 
dependence from help in everyday life and 
conditions, typical for elderlies, in particular geriatric 
syndrome and frailty in patients with CHD and ACS. 
Such age-related geriatric syndromes and conditions 
as malnutrition syndrome (nutrition scarcity 
syndrome), sarcopenia (age-related decrease in 
muscle strength and muscle mass), a decrease in the 
metabolic index and physical activity are involved in 
the development of frailty [10,6,7]. Some authors 
note unfavorable combination of cardiovascular 
diseases' risk factors and mutual deterioration of 
status in patients with frailty and CHD [2,5,11].  
 
Therefore, analysis of frailty impact on outcome in 
patients with CHD and development of ACS seems to 
be relevant. 
 
Study objectives. To study the course and outcomes 
of acute coronary syndrome with ST-segment 
elevation and without ST-segment elevation in 
patients of older age groups with frailty.  
 
Study materials and methods. The research was a 
retrospective, current and prospective study of the 
registers of patients with acute coronary syndrome 
within the framework of the international project 
“GIRAFFE – Gerontological Research International 
Against Frailty: Fit Experience” for 2011-2115 years 
[8,11]. The study was approved by the local ethics 
committees of clinical researches and conducted in 
accordance with international principles of 
biomedical ethics. All patients gave informed consent 
for inclusion in the study. 
 
The subject of the study was represented by a cohort 
of patients with CHD. During one year 1635 patients 
were examined. Of these, 1002 patients in middle 
age, 633 patient of elderly and frailty age. Among 
patients of elderly and senile age 368 have been 
diagnosed with frailty, 265 patients were not 
diagnosed with frailty. 
 
Diagnosis of frailty has been conducted on the basis 
of the specialized geriatric examination with the help 
of the original computer program "Comprehensive 
Geriatric Assessment" (State Registration Certificate 
No. 2016615973. Registered by the Federal Service 
for Intellectual Property (ROSPATENT) [Gorelik S. 
et al. 2016]. This program includes English electronic 
versions of the scales "Functional mobility 
assessment in elderly patients", "Mini nutritional 
assessment" (MNA), "Philadelphia geriatric morale 
scale", test " Mini-mental state examination" and the 
Barthel index, which allow to evaluate the main 
geriatric syndromes and determine the severity of 
frailty. 
 
All patients were divided into 2 groups: 
Group 1 – patients with ACS with ST-
segment elevation (n=961),  
Group 2 – patients with ACS without ST-
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segment elevation (n = 674).   
Each group was divided into subgroups: 
1.1 - patients of middle age with ACS with 
ST-segment elevation (n= 598), 
1.2 - patients of older age groups with ACS 
with ST-segment elevation and with frailty (n=129),  
1.3 - patients of older age groups with ACS 
with ST-segment elevation and without frailty 
(n=234);  
2.1 - patients of middle age with ACS 
without ST-segment elevation (n= 674), 
2.2 - patients of older age groups with ACS 
without ST-segment elevation and with frailty 
(n=96),  
2.3 - patients of older age groups with ACS 
without ST-segment elevation and without frailty 
(n=174).  
Frailty was diagnosed in 26.5% of elderly patients 
and 65.6% of senile patients. That is, among elderly 
patients with ACS with ST-segment elevation frailty 
was diagnosed in 72 patients, among senile people – 
in 57 patients. Among elderly patients with ACS 
without ST-segment elevation frailty was diagnosed 
in 56 elderlies, among senile patients –  in 40 
patients.  
 
For examined patients with ACS one of four 
treatment strategies was selected in accordance with 
European and national guidelines for management of 
patients with acute coronary syndrome and following 
patients’ management protocols, including 
organizational capabilities: 
1) emergency invasive – within the first two 
hours of admission to hospital,  
2) early invasive– within the first 24 hours 
from admission,  
3) late (deferred) invasive – within 72 hours 
from admission,  
4) conservative strategy.  
Among patients in the 1st group (patients with 
ACS with ST elevation) conservative therapy was 
conducted in 182 patients, among them 135 patients 
initially underwent thrombolysis (74.2%).  
 
In subgroup 1.1, conservative therapy was performed 
in 41 patients (6.9%), of whom 23 (59.1%) initially 
underwent thrombolysis. 
 
In subgroups 1.2, 1.3, conservative therapy was 
performed in 141 patients (38.8%), of which 112 
(79.4%) underwent thrombolysis. Then, 114 (84.4%) 
patients who had undergone thrombolysis initially 
underwent delayed angioplasty. Among them are 16 
middle aged patients and 98 patients of older age 
groups. 
 
We analyzed the effect of frailty on the outcomes of 
each of the strategies. 
 
Study results. To evaluate the results of unfavorable 
coronary events, we selected two indicators: the first 
one – according to the MACE criteria (Major 
Adverse Coronary Events), the second one –  
according to the intra-hospital mortality data.  
 
The development of adverse cardiac events was 
determined by the MACE scale criteria, which 
includes the development of a lethal outcome, MI, 
CABG, or repeated unplanned intervention.  
 
The average intrahospital lethality in the hospital 
where this study was performed in patients with ACS 
was 17.1% per year for patients with ST-segment 
elevation and 2.9% for patients without ST-segment 
elevation. Over 12 months of follow-up, adverse 
outcomes were assessed after strategies for treatment 
of patients with ACS. We obtained the following 
results, given in Table 1.  
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Table 1:Development of unfavorable outcome in terms of intra-hospital 
lethality in patients with ACS (%) 
Unfavorable outcome evaluation  Strategies  
Conservative  Invasive  
Emergency Early Late 
Development of unfavorable outcome in patients with ACS with ST segment elevation in relation to strategies of 
chosen therapy (%) 
Intrahospital lethality: 
middle age (n=598) 9.0 1.2* 2.1** 3.9***,## 
older age groups 
     without frailty (n=234) 
     with frailty (n=129) 
 
10.1 
19.2 
 
2.8* 
9.0* 
 
8.6# 
17.5# 
 
9.4## 
17.1 
Development of unfavorable outcome in patients with ACS without ST segment elevation in relation to 
strategies of chosen therapy (%) 
Intrahospital lethality: 
middle age (n=404) 2.0 1.2 1.1** 1.9 
without frailty  
     without frailty (n=174) 
     with frailty (n=96) 
2.1 
 
4.8 
1.1 
 
2.7* 
2.6# 
 
2.8 
2.5## 
 
3.0 
* p<0.05 between groups of patients with conservative and emergency invasive strategies;  
** p<0.05 between groups of patients with conservative and early invasive strategies;*** p<0. 05 between groups of 
patients with conservative and late invasive strategies; # p<0.05 between groups of patients with emergency invasive 
and early invasive strategies; ## p<0. 05 between groups of patients with emergency invasive and late invasive 
strategies; 
 
 
The obtained data show that in patients with ACS 
with ST-segment elevation receiving conservative 
therapy, the risk of adverse cardiac events is higher 
than in patients undergoing invasive therapy. When 
associated with frailty, the development of adverse 
cardiac events becomes more frequent. The excess of 
the average intrahospital lethality was observed only 
in elderly and frailty patients with frailty 
development, and to a greater extent in conservative 
therapy, despite the fact that the majority of such 
patients underwent thrombolysis followed by delayed 
angioplasty. 
 
Patients with ACS without an ST-segment elevation 
had similar risks of developing adverse coronary 
events. When joining frailty development of adverse 
coronary events significantly increased. In this group 
of patients, the excess of the average intrahospital 
lethality was also observed only in elderly and senile 
patients with frailty, and to a greater extent during 
conservative therapy, which leads to the conclusion 
that frailty has an adverse effect on the outcomes of 
ACS in older age groups. Also attracts attention more 
unfavorable prognoses for ACS with ST-segment 
elevation compared to patients with ACS without ST-
segment elevation in groups with frailty, and without 
it. 
 
We also analyzed complications based on the MACE 
scale in patients with ACS with ST elevation and in 
patients with ACS without ST elevation. Studied the 
frequency of repeated revascularization, repeated 
myocardial infarction (MI), acute cerebrovascular 
accident (ACVA), as well as the number of deaths 
within 1 year. Data on complications based on the 
MACE scale for patients with ACS with ST-segment 
elevation are shown in Table 2. 
 
IAJPS 2018, 05 (07), 6992-6997                Svetlana G. Gorelik et al                 ISSN 2349-7750 
 
 
 
w w w . i a j p s . c o m  
 
Page 6996 
Table 2:Development of unfavorable outcomes in patients with ACS with ST-segment elevation in relation to 
age and presence of frailty, (%) 
Unfavorable outcome by MACE Middle age 
(n=598) 
 
Older age groups 
without frailty 
(n=234) 
with frailty (n=129) 
Repeated revascularizations number (%) 8.2 9.1 15.3 
Repeated MI number (%) 9.3 11.1 23.2**,*** 
ACVA (%) 3.2 25.1* 33.6**,*** 
Number of deaths within the year (%) 2.3 5.3* 9.6**,*** 
* p<0.05 between groups of middle-aged patients and a group of older age patients without frailty; ** p<0. 05 
between groups of middle-aged patients and a group of older age patients with frailty; *** p<0. 05 between groups 
of older age patients. 
 
Data on complications based on the MACE scale for patients with ACS without ST segment elevation are shown in 
Table 3. 
Table 3: Development of unfavorable outcomes in patients with ACS with ST-segment elevation in relation to 
age and presence of frailty (%) 
Unfavorable outcome by MACE Middle age 
(n=404) 
Older age groups 
without frailty 
(n=174) 
with frailty  
(n=96) 
Repeated revascularizations number (%) 10.1 17.1 29.5**,*** 
Repeated MI number (%) 14.3 19.1 28.5**,*** 
ACVA (%) 2.2 24.1* 32.6** 
Number of deaths within the year (%) 1.3 2.5* 5.9**,*** 
* p<0. 05 between groups of middle-aged patients and a group of older age patients without frailty; ** p<0. 05 
between groups of middle-aged patients and a group of older age patients with frailty; *** p<0. 05 between groups 
of older age patients. 
 
Thus, in patients with ACS without ST-segment 
elevation, MACE index is high due to developed 
ACVA and equally due to the number of repeated 
revascularizations and myocardial infarctions. It 
should be noted that the number of deaths during the 
year in patients with ACS with ST-segment elevation 
is higher than in the group with ACS without ST-
segment elevation. Patients of older age groups in 
groups with frailty having ACS with ST-segment 
elevation and without ST-segment elevation had 
significantly more frequent complications by the 
MACE scale, and had significantly more deaths 
compared to elderly and senile patients without 
frailty. 
 
CONCLUSION: 
 Today, invasive methods used in patients with acute 
coronary syndrome with ST-segment elevation and 
without ST-segment elevation are gaining increasing 
effectiveness and popularity. Elderly and frailty 
patients make a special group of high risk. In the 
course of our study, we managed to prove that 
patients without frailty have better prognosis for the 
development of intrahospital mortality, according to 
the evaluation of adverse outcomes by the MACE 
scale, in particular the number of repeated 
revascularizations, the number of repeated 
myocardial infarctions, the number of acute 
cerebrovascular accidents, the number of deaths in a 
year, than patients with frailty. The more unfavorable 
predictions for ACS with ST-segment elevation are 
noteworthy in comparison with patients with ACS 
without ST-segment elevation in groups with frailty, 
and without it. Patients of older age groups in groups 
without frailty having ACS with ST-segment 
elevation and without ST-segment elevation had 
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significantly fewer complications by the MACE 
scale, and had significantly fewer deaths compared 
with elderly and senile patients with frailty, in 
particular 1.8 and 2.4 times less deaths, respectively.  
 
Thus, correction of frailty can improve the results of 
treatment of patients with ACS with ST-segment 
elevation and without ST-segment elevation by 
leveling the negative impact of frailty on the outcome 
of treatment of acute coronary syndrome. 
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